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ABSTRACT
Initiation of DNA replication in eukaryotes is exquis-
itely regulated to ensure that DNA replication occurs
exactly once in each cell division. A conserved and
essential step for the initiation of eukaryotic DNA
replication is the loading of the mini-chromosome
maintenance 2–7 (MCM2–7) helicase onto chro-
matin at replication origins by Cdt1. To elucidate
the molecular mechanism of this event, we
determined the structure of the human Cdt1-Mcm6
binding domains, the Cdt1(410–440)/MCM6(708–821)
complex by NMR. Our structural and site-directed
mutagenesis studies showed that charge comple-
mentarity is a key determinant for the specific inter-
action between Cdt1 and Mcm2–7. When this
interaction was interrupted by alanine substitutions
of the conserved interacting residues, the corres-
ponding yeast Cdt1 and Mcm6 mutants were defect-
ive in DNA replication and the chromatin loading of
Mcm2, resulting in cell death. Having shown that
Cdt1 and Mcm6 interact through their C-termini,
and knowing that Cdt1 is tethered to Orc6 during
the loading of MCM2–7, our results suggest that
the MCM2–7 hexamer is loaded with its C terminal
end facing the ORC complex. These results provide
a structural basis for the Cdt1-mediated MCM2–7
chromatin loading.
INTRODUCTION
To maintain genome integrity, DNA replication in eu-
karyotic cells is tightly regulated to ensure that the
genome is replicated exactly once per cell cycle. This regu-
lation is achieved through a two-step mechanism, the
loading of the replicative DNA helicase, which includes
the MCM2-7 complex as a major component and activa-
tion of this helicase (1).
The loading of the MCM2–7 complex requires the
coordinated action of several proteins, most notably the
six-subunit origin recognition complex (ORC), the cell
division cycle 6 homolog (Cdc6), the chromatin licensing
and DNA replication factor 1 (Cdt1) (2,3). The ﬁrst step
of this process is the binding of ORC to the replication
origin on newly synthesized chromatin followed by the
recruitment of Cdc6 and Cdt1. These two factors then
recruit the MCM2–7 complex to form a prereplicative
complex (pre-RC) during the late M and G1 phases
(4,5). Activation of the pre-RC requires the sequential
assembly of additional factors including Cdc45 and the
GINS complex in a DDK- and S-CDK-dependent
manner, culminating in the initiation of DNA replication
in S-phase (6,7).
The MCM2–7 complex was ﬁrst identiﬁed as a family of
genes required for minichromosome maintenance in
Saccharomyces cerevisiae (8). All six paralogous MCM
proteins belong to the highly diversiﬁed AAA+
(ATPases associated with a variety of cellular activities)
protein family (9). Structural analysis showed that the six
MCM proteins form a double hexameric ring with
head-to-head conﬁguration, and DNA passes through
the central channel of the double hexamer (10–12). The
hexamer shows weak helicase activity in vitro (13–15).
The licensing factor Cdt1 is a critical component of the
pre-RC, and its primary function is to recruit the MCM2–
7 complex to the replication origin (16). Overexpression of
Cdt1 alone in many types of mammalian cell lines causes
rereplication of DNA (17–19).
Recently results showed that the Cdt1 MCM2–7
hepatmer is loaded onto DNA cooperatively to form a
double hexamer (12). Previous studies on the interactions
between Cdt1 and individual members of the MCM2–7
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Mcm6 (16,20–22). The region of Cdt1 involved in the
MCM2–7 interaction has been deﬁned. Cdt1 binds to
MCM2–7 complex through the region spanning residues
447–620 in Xenopus (16) and residues 407–477 of Cdt1
bind to Mcm6 in mouse (20). On the basis of the yeast
two-hybrid assay we found that the interaction between
human Mcm6 and Cdt1 is much stronger than that
between Mcm2 and Cdt1. We further demonstrated that
the conserved C-terminal domain of the human Mcm6
(residues 707–821) physically interacts with Cdt1
(residues 410–445) (23). However, the detailed molecular
mechanism underlying the chromatin loading of the
MCM2–7 complex through Cdt1 remains elusive.
In the present study, we determined the solution
complex structure of the Cdt1-Mcm6 binding domains,
the C-terminal helix (411–440) of Cdt1 binds to the
C-terminal region (708–821) of Mcm6. In vivo studies in
S. cerevisiae showed that interruption of this interaction
prevented the loading of Mcm2 onto chromatin, inhibited
DNA replication, and prevented cell proliferation. Our
results reported here provided a structural basis for the
Cdt1 mediated MCM2–7 chromatin loading.
MATERIALS AND METHODS
Sample preparation
Human Mcm6 C-terminal Cdt1-binding domain (hCBD)
and the Mcm6-binding domain (hMBD) of human Cdt1
were expressed, enriched with
13C and
15N stable isotopes
in Escherichia coli and puriﬁed essentially as described
previously (23).
NMR spectroscopy
NMR spectra were acquired at 37 C on 750- and
500-MHz Varian NMR spectrometers with self-shielded
z-axis gradients. All spectra were processed using
NMRPipe (24,25) and analyzed using SPARKY 3
(Goddard and Kneller, University of California, San
Francisco, CA, USA). The
1H,
15N and
13C resonances
of backbone and side-chain atoms were assigned by using
a standard set of triple resonance experiments on either
uniformly
15N,
13C-labeled hCBD with/without unlabeled
MBD or uniformly
15N,
13C-labeled hMBD with/without
unlabeled hCBD, at protein concentrations of  0.6mM
(26). The hMBD–hCBD complex was prepared at a 1:2
ratio between
15N,
13C-labeled and unlabeled components.
NOE-derived distance restraints were obtained from
15N-
or
13C-edited 3D NOESY spectra each with a mixing time
of 120ms, complemented by
13C-edited,
13C/
15N-ﬁltered
3D NOESY spectra for the intermolecular contact
(mixing time: 150ms) (27).
NOE analysis and structure calculations
NOE assignment and structure calculations were per-
formed using the program CYANA2.1 (28) for either
hMBD or hCBD in the complex form. The initial 250
complex structures of hCBD and hMBD were generated
with unambiguous intermolecular NOE restraints by CNS
1.1 (29). The 100 top scoring complex structures from
CNS were further reﬁned with additional chemical shift
perturbation data using HADDOCK 1.3 (30). The quality
of the structures was assessed using PROCHECK (31).
All of the ﬁgures representing the structures
were generated by Pymol (http://www.pymol.org).
The statistics of the structure reﬁnement and the quality
of the ﬁnal structures are summarized in Table 1 for the
hMBD/ hCBD complex, Supplementary Table S1 for
hMBD.
Binding studies
To investigate the ligand binding, the 2D
1H-
15N-HSQC
spectra were recorded on uniformly
15N-labeled hMBD
( 0.2mM) in the presence of different concentrations of
hCBD ranging from 0 to 1.5mM. Both the hMBD sample
and the stock solutions of hCBD were prepared in the
NMR buffer (50mM sodium phosphate, 50mM NaCl,
5% glycerol and 1mM EDTA, pH 7.5). The chemical
shift perturbation between the free-form and
hCBD-bound hMBD was normalized by the following
formula and expressed in ppm:
Chemical shift perturbation ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð HÞ
2+
 N
6
   2
s
,
where  H and  N are the differences in chemical shifts
of amide protons and nitrogen between the initial and
ﬁnal data points of the titration, respectively.
Site-directed mutagenesis study of the interaction between
hCBD–Mcm6 and hMBD–Cdt1
The binding residues were conﬁrmed by site-directed
mutagenesis studies based on the information from the
chemical shift perturbation experiment. The point
mutants A414G, R425A, I426A, R427A, K429A,
K433A, Q434A, L435A and Q437A of hCdt1 were ex-
pressed in E. coli and puriﬁed to homogeneity.
Strains, plasmids and antibodies
The strains and plasmids used in this study were described
in Tables 2 and 3. Anti-Orc3 and anti-Mcm2 antibodies
were kind gifts from B. Stillman. Anti-HA antibodies were
purchased from Roche.
Cell cycle synchronization and ﬂow cytometry
Cell cycle block and release with a-factor or nocodazole
were carried out as described previously (32). Flow
cytometry was performed as previously described (33).
mcm6-td cells (S. cerevisiae) expressing yeast AD-Mcm6
or AD-Mcm6-5A and cdt1-td cells (S. cerevisiae) express-
ing yeast BD-Cdt1 or BD-Cdt1-3A were synchronized in
M phase before being shifted to 37 C for 1h to degrade
the Mcm6-td or Cdt1-td protein. Cells were then released
into fresh medium containing a-factor (a-F) at 37 C for
2h and then released into fresh medium at 37 C.
Nucleic Acids Research,2012, Vol.40, No. 7 3209Chromatin binding assay
The chromatin-binding assay to examine chromatin-
associated proteins was performed as previously described
(33). mcm6-td cells (S. cerevisiae) expressing yeast
AD-Mcm6 or AD-Mcm6-5A were synchronized in M
phase by nocodazole (Noc) and then shifted to 37 C for
1h to deplete the Mcm6-td protein before being released
into G1 phase in fresh medium containing a-factor at
37 C for 2h. cdt1-td cells containing the plasmid express-
ing BD-Cdt1 or BD-Cdt1-3A were synchronized in M
phase and then shifted to 37 C for 1.5h before being
released into fresh medium containing a-factor at 37 C
for 2h. Samples were taken at 30-min intervals. The chro-
matin fraction (Chr.) and whole cell extracts (WCE) from
the cells were immunoblotted.
Data deposition
Atomic coordinate has been deposited at Protein Data
Bank for the Cdt1–Mcm6 complex (code-2LE8).
RESULTS
Mapping the hMcm6 binding sites and determining the
structure of hMBD
To circumvent the challenge of studying the large MCM2–
7 and Cdt1 protein assembly by X-ray and NMR tech-
niques, we conducted an extensive mapping of the
interaction domains of the human MCM–Cdt1 complex.
We showed that Cdt1 speciﬁcally interacts with Mcm6
(also conﬁrmed in yeast) through Cdt1 410–445, the
human Mcm6-binding domain of Cdt1 (hMBD) and
Mcm6 708–821, the human Cdt1-binding domain of
Mcm6 (hCBD) (23). To determine the structure of the
interacting domains of the human MCM6 and Cdt1
complex (hCBD/hMBD), we ﬁrst determined the individ-
ual structures of hCBD and hMBD by NMR spectros-
copy. We previously reported the structure of hCBD
Table 1. Statistics of the NMR structure of the hCBD–hMBD complex
NMR restraints
Total experimental restraints 1780
Total NOE distance restraints 1460
Short-range, ji jj 1 773
Medium-range, 1<ji jj<5 352
Long-range, ji jj 5 235
Intra MBD 90
Inter CBD-MBD 10
Dihedral angle restraints(CBD+MBD)
Phi 160
Psi 160
Statistics for structures
Final Energies (kcal/mol)
van der Waals (kcal/mol)  447.129±20.737
NOE (kcal/mol) 1.61991±0.8470
Violations
Number of NOE violations>0.5A ˚ 0±0
R.m.s. deviation (A ˚ ) from experimental distance restraints 0.0323±0.0094
Number of dihedral angle constraint violations>5  0±0
R.m.s. deviation ( ) from experimental torsion restraints 0.3751±0.0795
Deviations from idealized geometry
Bonds (A ˚ ) 0.00344±0.0001
Angles ( ) 0.40165±0.0200
Improper ( ) 0.47657±0.0223
Structural RMSD to the mean coordinate
region (residue number) bb/heavy (A ˚ )
708–821,411–440 3.922/4.171
718–737,745–756,763–780,787–789,811–813,421–433 0.764/1.345
Ramachandran plot (% residues)
Residues in most favored regions 80.5
Residues in additional allowed regions 16.10
Residues in generously allowed regions 2.10
Residues in disallowed regions 1.30
Table 3. Plasmids
Plasmid Description
PL1808 pGBKT7-Cdt1
PL1843 pGBKT7- Cdt1-3A(R486A, L487A, R490A)
PL1815 pGADT7-Mcm6
PL1850 pGADT7-Mcm6-5A(E945A, D947A, L951A, E953A, Y954A)
Table 2. Yeast strains
Strain Genotype
YL135 W303-1a mcm6-td::URA3 ubr1D::GAL-UBR1::HIS3
YL1208 W303-1a cdt1-td ubr1D::GAL-UBR1::HIS3 leu2::pCM244x3
cdc54Dmcm4-GFP::TRP1
3210 Nucleic Acids Research, 2012,Vol.40, No. 7(23). In this study, we determined the hMBD structure,
which adopts an amphipathic a-helical conformation
(Figure 1a and b) containing residues 421–432
(Supplementary Table S1). NMR titration experiments
(Figure 2) showed that residues of hMBD that displayed
large chemical shift changes (>0.08ppm) corresponded to
amino acids on one side of the amphipathic helix formed
by residues Asp421, Glu424, Ala428, Lys429, Glu430,
Gln432, Lys433 (Figures 1a and b and 2), while residues
Leu422, Leu423, Ile426 and Arg427 completely dis-
appeared in the titrated HSQC spectra.
Three-dimensional structure of the hCBD–hMBD complex
To fully characterize this interaction at the atomic level,
we determined the structure of the hCBD–hMBD complex
which is well-deﬁned by the NMR data (described in
details under ‘Materials and Methods’ section). The 19
lowest energy structures are characterized by good
backbone geometry, with no signiﬁcant restraint violation,
and low pairwise rmsd values (Table 1). The structure of
hCBD in the complex presents a typical winged helix–
turn–helix (HTH) fold as previously reported: the
canonical three-helix bundle is packed against two short
antiparallel b strands. The core region of the hMBD
peptide (residues 421–432) adopts a well-deﬁned amphi-
pathic a-helical conformation, whereas the N- and
C-terminal ﬂanking residues are ﬂexible and do not
display a deﬁned secondary structure (Figure 1c and d).
The orientation of the peptide is deﬁned by unambiguous
intermolecular NOEs (Figure 3) and the structure of
hCBD was validated by residual dipolar couplings
(RDC) (Supplementary Figure S1). The size of the
protein–peptide binding interface is &1260 A ˚ 2, indicating
relative strong binding, which is consistent with the NMR
titration experiment showing an intermediate binding.
Important interactions at the hCBD–hMBD interface
The binding interface of the hCBD–hMBD complex com-
prises the helix-turn-helix region formed by helix a2, loop2
and helix a3 of hCBD. The hMBD binding site on hCBD
is characterized by a hydrophobic surface formed by
Ile760, Leu766, Ile767 that engages the hydrophobic
residues Leu423, Ile426 and makes van der Waals
contacts with the side chains of Lys429 and Lys433 of
Figure 1. Solution structure of hMBD of human Cdt1 and the Mcm6-Cdt1 complex. (a) The left panel shows the backbone superposition of the
20 lowest-energy NMR structures of hMBD. The a-helix is colored red. N-terminal and C-terminal ends are indicated as N and C. The right panel
shows a ribbon representation of the same structure of hMBD using the coordinates of the lowest energy structure. (b) Chemical shift perturbations
in the presence of hCBD are colored onto the structure of hMBD in the surface representation. Residues with chemical shift perturbations ranging
from 0.00 to 0.08ppm are colored in green while residues with chemical shift perturbations larger than 0.08ppm are shown in red and residues
disappeared in HSQC spectrum are in blue. (c) Backbone superposition of the 19 lowest-energy NMR structures. Secondary structural elements of
hCBD are color-coded: a-helices (red), b-strands (green), and loops (gray). hMBD is shown in blue. N-terminal and C-terminal ends are indicated as
N and C. (d) Ribbon diagram of the complex using the coordinates of the lowest energy structure. (e) Expanded view of the complex binding surface.
Residues having intermolecular NOEs are shown in sticks, yellow for hCBD and green for hMBD. The backbones of hCBD and hMBD are colored
gray and blue respectively. (f) Surface representation of hCBD colored by residue type: red, acidic; blue, basic; yellow, hydrophobic; gray,
non-interacting. hMBD is indicated as in (e) except that the backbone is in purple.
Nucleic Acids Research,2012, Vol.40, No. 7 3211hMBD. Additionally the basic residues Lys429 and
Lys433 of hMBD make a close contact with the acidic
residues E757 and E760 of hCBD, suggesting that
charge complementarity is a key determinant of the
observed hCBD–hMBD interactions (Figure 1e and f).
Mutagenesis studies of the interaction between hMBD
and hCBD
To investigate the structural requirements for the binding
of hMBD peptides by independent means, we identiﬁed
critical residues in the respective interaction motifs by mu-
tational analysis. Guided by the observation in the
chemical shift perturbation experiment, we performed
site-directed mutagenesis at several amino acid residues
of hMBD which are expected to interfere with the
binding between hCBD and hMBD. These point mutant
peptides A414G, R425A, I426A, R427A, K429A, K433A,
Q434A, L435A and Q437A were expressed and puriﬁed to
homogeneity. However, L422A could not be expressed in
E. coli. Pulldown assay (Figure 4a, Supplementary Figure
S2A) showed that changing residues R425, I426, K429
and K433 to alanines signiﬁcantly decreased the binding
afﬁnity as predicted from the structure. We noted that the
interaction is disrupted for the R425A mutant although
R425 does not have direct contact with the hMBD in the
hCBD/hMBD tertiary structure. We believe that there is a
conformational change in the R425A mutant, disrupts the
interaction between hCBD and hMBD. On the basis of
our previous mutational studies, the residues of hCBD
E757, E763 and L766 are crucial for the interaction at
the binding interface of the complex. Pulldown assays
were also performed using the hMBD mutants. The
charged residues R425, R427, K429 and K433 were
replaced with neutral (M) and opposite-charged (E)
amino acids of similar side chains. The similar results
obtained further support that charge complementarity is
the key determinant (Supplementary Figure S2B and C) of
the Cdt1–Mcm6 interaction. Together, these data demon-
strate that the interaction between hCBD and hMBD is
highly speciﬁc.
The interaction between hMBD and hCBD is crucial for
pre-RC assembly and DNA replication
To investigate the biological signiﬁcance of the Cdt1–
Mcm6 interaction through the residues identiﬁed by
NMR, we disrupted the Cdt1–Mcm6 interaction by
introducing the corresponding mutations on the highly
conserved MBD–CBD interacting surface in the budding
yeast (Figure 5). We constructed yeast mutants bearing
the combined E945A, D947A, L951A, E953A and
Y954A mutations in the CBD (Mcm6-5A) and the
combined R486A, L487A and R490A, alleles in the
MBD (Cdt1-3A) (Figure 5). GST retention assay
showed that each of the interface surface mutant
impaired the interaction between hCdt1 and hMcm6
as predicted by the structure (Figures 4a and 5,
Supplementary Figure S2A and B) and failed to support
cell proliferation (Figure 4d and e). Yeast two-hybrid
analysis also showed that Mcm6-5A and Cdt1-3A did
not interact with their corresponding wild-type partners
(data not shown).
The activation domain-Mcm6 fusion protein
(AD-Mcm6) and the DNA binding-domain-Cdt1 fusion
protein (BD-Cdt1) expressed from the yeast two-hybrid
plasmids are biologically functional. We expressed
AD-Mcm6 and AD-MCM6-5A in the mcm6-td
(td, temperature-inducible degron) cells, and BD-Cdt1
and BD-Cdt1-3A in cdt1-td cells to examine the effects
of Mcm6-5A and Cdt1-3A on cell viability, pre-RC for-
mation and DNA replication. To investigate if the Cdt1–
Mcm6 interaction is essential for the assembly of pre-RC,
we examined the chromatin association of pre-RC
proteins during the M-to-G1 transition in cells expressing
the AD-Mcm6-5A mutant at 37 C when the Mcm6-td
protein is depleted. The results showed that in cells ex-
pressing the wild-type AD-Mcm6, Mcm2 was loaded
onto chromatin at 30min after release from the M-phase
block (Figure 4b). In contrast, AD-Mcm6-5A did not
Figure 2. NMR studies of the interaction between hMBD and hCBD.
(a) Overlays of
1H-
15N HSQC spectra of
15N-labeled hMBD in free
form (black) titrated with hCBD at a molar ratio of 1:3 (blue), 1:6
(red). The arrows point to the shifted positions (black to red) of the
amide proton resonance. (b) Chemical shift differences between the
free-form and hCBD saturated hMBD. NMR titration experiments
show an intermediate exchange kinetics indicating a relatively strong
binding between hCBD and hMBD.
3212 Nucleic Acids Research, 2012,Vol.40, No. 7support pre-RC formation as shown by the absence of
Mcm2 on chromatin in G1 phase cells (Figure 4b).
Similarly, BD-Cdt1 but not BD-Cdt1-3A supported
pre-RC formation (Figure 4c).
To investigate if Mcm6-5A is defective for DNA repli-
cation, the DNA content of mcm6-td cells expressing
AD-Mcm6 or AD-Mcm6-5A after G1 arrest-and-release
was studied. The cells expressing AD-Mcm6 replicated
their DNA normally after the Mcm6-td protein was
depleted (Figure 4d). In contrast, cells expressing the
AD-Mcm6-5A mutant did not replicate their DNA as
evident from their failure to traverse S phase, even
though budding progressed normally (Figure 4d).
Similar results were obtained in Cdt1-depleted cells ex-
pressing BD-Cdt1-3A (Figure 4e). Therefore, mutations
on the interface surface that disrupted the Cdt1–Mcm6
interaction prevented pre-RC formation, DNA replication
and cell proliferation. Together, these results
demonstrated that the residues identiﬁed from the
hMBD–hCBD complex structure indeed mediate
MCM2–7 chromatin loading through the C-terminal
interaction of Cdt1 and Mcm6.
DISCUSSION
In this study, we determined the atomic structure of the
conserved C-terminal domain of human Mcm6 in complex
with the C-terminal region of Cdt1 by NMR spectroscopy
and identiﬁed the residues which are crucial for pre-RC
assembly in DNA replication. Our structural and func-
tional analyses in conjunction with previous studies
showed that Mcm6–Cdt1 interaction played a major role
in Cdt1-mediated MCM2–7 chromatin loading, a critical
and precisely regulated event during the initiation of rep-
lication in eukaryotes.
Structural studies showed that the C-terminus of human
Cdt1, the human Mcm6 binding domain (hMBD), adopts
an amphipathic a-helical conformation in the hCBD–
hMBD complex. The hCBD bears a winged-helix fold
that consists of a helix-turn-helix (HTH) motif followed
Figure 3. Intermolecular NOEs between hCBD and hMBD. The left two strips of a 3D F1
13C,
15N-ﬁltered, F2
13C-edited NOESY-HSQC spectrum
(150ms mixing time) of a sample containing
13C,
15N-labeled hCBD and unlabeled hMBD showing NOEs from the hMBD (I426, L422, the
ambiguous assignment is colored by blue) to the hCBD (K770, I767). The right strip of the same experiment of a sample containing
13C,
15N-labeled hMBD and unlabeled hCBD showing NOEs from the hCBD (L766, K770) to the hMBD (L422). CD1: the e1 carbon atom of the
Isoleucine methyl group; CD#: degenerate pairs of Leucine methyl carbon atoms; CE: the e carbon of the Lysine; HA: the a proton attached to a
carbon; QG: degenerate pairs of g methylene protons; HG: the g proton of Leucine; QG1: degenerate pairs of Isoleucine g1 methylene protons; QD:
degenerate pairs of d methylene protons; QE: degenerate pairs of e methylene protons; QD1: degenerate pairs of Isoleucine d1 methyl protons; QQD:
degenerate pairs of Leucine methyl protons.
Nucleic Acids Research,2012, Vol.40, No. 7 3213by the wing (b–loop–b) motif. The hCBD binds to one
side of hMBD through the HTH region (helix a2—
loop2—helix a3). Structural analysis on the binding
surface show that residues Ile760, Leu766 and Ile767 of
hCBD make hydrophobic contributions to the complex
through interaction with residues Leu423, and Ile426 of
hMBD. In addition, the acidic residues of E757 and E760
of hCBD engage in close contacts with the side chains of
Lys429 and Lys433 of hMBD, suggesting that charge
complementarity is essential for the hCBD–hMBD
interactions.
To verify the binding mode for the observed inter-
actions in hCBD–hMBD complex, the structure-based
site-directed mutagenesis study was performed on the
residues located on the binding surface. The GST
pull-down assay indicates that the point mutant R425A,
I426A, K429A and K433A signiﬁcantly decreased the
binding afﬁnity. Previous studies showed that point mu-
tations of residues Leu766, E757 and E760 on hCBD sig-
niﬁcantly reduced the binding between hCBD and hMBD.
In our previous work we found that the interaction
between human Mcm6 and Cdt1 is much stronger than
that between Mcm2 and Cdt1 (23). Based on the align-
ment of the WH domains of the MCM proteins
(Supplementary Figure S3), the charged residues of
Mcm6 required for Cdt1 binding (E757 and E760) are
not conserved among the MCM proteins, consistent
with the observation that Cdt1 only interacts strongly
with Mcm6. These results together conﬁrmed the strong
and speciﬁc interactions in hCBD–hMBD complex.
Disrupting the Cdt1–Mcm6 interaction in budding
yeast by the Cdt1-3A or Mcm6-5A mutants prevented
pre-RC formation and resulted in DNA replication
defect. The sequence conservation of these two domains
suggests that the mutated residues play an important and
evolutionarily conserved role in the loading of the
MCM2–7 complex during DNA replication licensing in
eukaryotes. The conserved binding residues among differ-
ent species underscore the biological signiﬁcance of this
interaction.
Current information suggests that the MCM2–7
helicase is recruited to ORC by tethering Cdt1 to Orc6
during pre-RC formation (35). The spacing and orienta-
tion of the Cdt1–Mcm6 interaction domains determined
Figure 4. Disruption of the Cdt1–Mcm6 interaction by mutations on their interacting surfaces impaired pre-RC formation and DNA replication.
(a) Wild-type and mutants of hMBD were pulled down by GST-tagged wild-type hCBD and visualized by Coomassie Blue staining. (b)Chromatin
loading of Mcm2 (S. cerevisiae) is interrupted by the Mcm6-5A mutant (Supplementary Material). (c) Chromatin loading of Mcm2 (S. cerevisiae)i s
interrupted by the Cdt1-3A mutant (Supplementary Data). (d) Mcm6-5A cells arrest in S-phase with large buds (S. cerevisiae) (Supplementary Data).
Flow cytometry was performed for the cell samples taken at the indicated time points. % Bud. percentage of budding cells. (e) Cdt1-3A cells arrest in
S-phase as in (d).
3214 Nucleic Acids Research, 2012,Vol.40, No. 7here provide further insight into the loading mechanism of
the MCM2–7 helicase. Because Cdt1 interacts with Mcm6
via their C-terminal regions, the MCM2–7 complex must
be loaded with its C-terminal end facing ORC (Figure 6).
Furthermore, the position of the Cdt1 binding site on the
extreme C-terminal region of the MCM2–7 hexamer
suggests that the two Cdt1-binding sites on a single Orc6
are too close to accommodate the independent loading of
two MCM2–7 hexamers by two Orc6-bound Cdt1 (36).
The spatial constraint suggested by our structure
supports alternative loading mechanisms such as the
loading of the head-to-head MCM2–7 double hexamer
by a single Cdt1 or the independent loading of the
MCM2–7 hexamer by two Cdt1 associated with a
dimeric ORC.
Structural information related to the MCM protein
family is accumulating, including the crystal structures
of the N-terminal domains of MthMCM (10) and
SsoMCM (37), the low resolution three-dimensional
electron microscopy (EM) reconstructions of the
full-length MthMCM (38–40) and the near full length
SsoMCM (41) as well as the EM structures of MCM2–7
complex of yeast proteins (11,12) and Drosophila
melanogaster (7). Numerous structural studies on the key
residues and the relevant region of Cdt1 that bind the
MCM proteins have been reported (42,43). However,
none of these studies provided detailed structural informa-
tion on the Cdt1-mediated MCM2–7 chromatin loading.
We believe that the complex structure presented here
uniquely provides mechanistic insights for the Cdt1-
mediated MCM2–7 chromatin loading.
In conclusion, we present the solution structure of
hCBD/hMBD complex by NMR spectroscopy and
identiﬁed the interacting residues of Mcm6 and Cdt1 es-
sential for the chromatin loading of the MCM2–7
hexamer in the initiation of DNA replication. Our
Figure 5. Alignments of the Cdt1 and Mcm6 sequences from different organisms. (a) Multiple sequence alignment of a representative set of Mcm6
proteins: Q14566, H. sapiens; P97311, Mouse; BAF94254, Rattus norvegicus; Q5FWY4, XENLA; Q9V461, D. melanogaster; P4973, S. pombe; P53091,
S. cerevisiae. The dashes indicate the positions of gaps in eukaryotic sequences. Secondary structural elements at the top of the alignment are
indicated with color coding as in Figure 1a and b. (b) Multiple sequence alignment of a representative set of the C-terminal regions of Cdt1: Q9H211,
H. sapiens; Q8R4E9, Mouse; D3ZKD4, Rattus norvegicus; Q9I9A7, XENLA; Q7JVY2; D. melanogaster; P40382, S. pombe; P47112, S. cerevisiae. The
sequence alignment was produced with ClustalX(34). Blue arrows indicate the amino acids that greatly reduce the interaction between Mcm6 and
Cdt1 upon Ala substitution. Residues are gray-scaled based on percentage identity.
Figure 6. Proposed model for the Cdt1/MCM2-7 recruitment and
MCM hexmer loading events. The Cdt1 functions as the bridge to
bring Orc6 and MCM2–7 together to form pre-RC. The C-terminal
Mcm6-binding domain of Cdt1 tethers MCM2–7, while the
N-terminal Orc6-binding domain recruits Cdt1/MCM2-7 to ORC
complex.
Nucleic Acids Research,2012, Vol.40, No. 7 3215results provide in molecular detail a structural basis for
the essential role of Cdt1 in loading the MCM2–7 complex
onto chromatin during pre-RC assembly.
ACCESSION NUMBER
PDB code: 2LE8
SUPPLEMENTARY DATA
Supplementary Data are available at NAR online:
Supplementary Table 1, Supplementary Figures 1–3,
and Supplementary references [44].
FUNDING
Funding for open access charge: Hong Kong Research
Grants Council [RGC664109 and RGC663911], AoE/
M-06/08, TUYF10SC03; and HKUST Research Fund.
Conﬂict of interest statement. None declared.
REFERENCES
1. Remus,D. and Difﬂey,J.F. (2009) Eukaryotic DNA replication
control: lock and load, then ﬁre. Curr. Opin. Cell. Biol., 21,
771–777.
2. Bell,S.P. and Dutta,A. (2002) DNA replication in eukaryotic cells.
Annu. Rev. Biochem., 71, 333–374.
3. Difﬂey,J.F.X. (2004) Regulation of early events in chromosome
replication. Curr. Biol., 14, 778–786.
4. Maiorano,D., Moreau,J. and Mechali,M. (2000) XCDT1 is
required for the assembly of pre-replicative complexes in X.
laevis. Nature, 404, 622–625.
5. Liang,C., Weinreich,M. and Stillman,B. (1995) ORC and Cdc6p
interact and determine the frequency of initiation of DNA
replication in the genome. Cell, 81, 667–676.
6. Masai,H., Sato,N., Takeda,T. and Arai,K. (1999) CDC7 kinase
complex as a molecular switch for DNA replication. Front
Biosci., 4, 834–840.
7. Costa,A., Ilves,I., Tamberg,N., Petojevic,T., Nogales,E.,
Botchan,M.R. and Berger,J.M. (2011) The structural basis for
MCM2-7 helicase activation by GINS and Cdc45. Nat. Struct.
Mol. Biol., 18, 471–477.
8. Maine,G.T., Shiha,P. and Tye,B.K. (1984) Mutants of
S. Cerevisiae. defective in the maintenance of minichromsome.
Genetics, 106, 356–385.
9. Neuwald,A.F., Aravind,L., Spouge,J.L. and Koonin,E.V. (1999)
AAA+: a class of chaperone-like ATPases associated with the
assembly, operation, and disassembly of protein complexes.
Genome Res., 9, 27–43.
10. Fletcher,R.J., Bishop,B.E., Leon,R.P., Sclafani,R.A., Ogata,C.M.
and Chen,X.S. (2003) The structure and function of MCM from
archaeal M. thermoautotrophicum. Nat. Struct. Biol., 10, 160–167.
11. Evrin,C., Clarke,P., Zech,J., Lurz,R., Sun,J., Uhle,S., Li,H.,
Stillman,B. and Speck,C. (2009) A double-hexameric MCM2–7
complex is loaded onto origin DNA during licensing of
eukaryotic DNA replication. Proc. Natl Acad. Sci., 106,
20240–20245.
12. Remus,D., Beuron,F., Tolun,G., Grifﬁth,J.D., Morris,E.P. and
Difﬂey,J.F. (2009) Concerted loading of MCM2-7 double
hexamers around DNA during DNA replication origin licensing.
Cell, 139, 719–730.
13. Davey,M.J., Indiani,C. and O’Donnell,M. (2003) Reconstitution
of the MCM2–7p heterohexamer, subunit arrangement, and ATP
site architecture. J. Biol. Chem., 278, 4491–4499.
14. Schwacha,A. and Bell,S.P. (2001) Interactions between two
catalytically distinct MCM subgroups are essential for
coordinated ATP hydrolysis and DNA replication. Mol. Cell, 8,
1093–1104.
15. Bochman,M.L. and Schwacha,A. (2008) The MCM2-7 complex
has in vitro helicase activity. Mol. Cell, 31, 287–293.
16. Ferenbach,A., Li,A., Brito-Martins,M. and Blow,J.J. (2005)
Functional domains of the Xenopus replication licensing factor
Cdt1. Nucleic Acids Res., 33, 316–324.
17. Arentson,E., Faloon,P., Seo,J., Moon,E., Studts,J.M.,
Fremont,D.H. and Choi,K. (2002) Oncogenic potential of the
DNA replication licensing protein CDT1. Oncogene, 21,
1150–1158.
18. Tatsumi,Y., Sugimoto,N., Yugawa,T., Narisawa-Saito,M.,
Kiyono,T. and Fujita,M. (2006) Deregulation of Cdt1 induces
chromosomal damage without rereplication and leads to
chromosomal instability. J. Cell. Sci., 119, 3128–3140.
19. Seo,J., Chung,Y.S., Sharma,G.G., Moon,E., Burack,W.R.,
Pandita,T.K. and Choi,K. (2005) Cdt1 transgenic mice develop
lymphoblastic lymphoma in the absence of p53. Oncogene, 24,
8176–8186.
20. Yanagi,K., Mizuno,T., You,Z. and Hanaoka,F. (2002) Mouse
geminin inhibits not only Cdt1-MCM6 interactions but also a
novel intrinsic Cdt1 DNA binding activity. J. Biol. Chem., 277,
40871–40880.
21. Teer,J.K. and Dutta,A. (2008) Human Cdt1 lacking the
evolutionarily conserved region that interacts with MCM2-7 is
capable of inducing re-replication. J. Biol. Chem., 283, 6817–6825.
22. You,Z. and Masai,H. (2008) Cdt1 forms a complex with the
minichromosome maintenance protein (MCM) and activates its
helicase activity. J. Biol. Chem., 283, 24469–24477.
23. Wei,Z., Liu,C., Wu,X., Xu,N., Zhou,B., Liang,C. and Zhu,G.
(2010) Characterization and structure determination of the Cdt1
binding domain of human minichromosome maintenance (MCM)
6. J. Biol. Chem., 285, 12469–12473.
24. Delaglio,F., Grzesiek,S., Vuister,G.W., Zhu,G., Pfeifer,J. and
Bax,A. (1995) NMRPipe: a multidimensional spectral processing
system based on UNIX pipes. J. Biomol. NMR., 6, 277–293.
25. Zhu,G. and Bax,A. (1992) Improved linear prediction of
truncated damped sinusoids using modiﬁed backward-forward
linear prediction. J. Magn. Reson., 100, 202–207.
26. Sattler,M., Schleucher,J. and Griesinger,C. (1999) Heteronuclear
multidimensional NMR experiments for the structure
determination of proteins in solution employing pulsed ﬁeld
gradients. Prog. Nucl. Magn. Reson. Spectrosc., 34, 93–158.
27. Zwahlen,C., Legault,P., Vincent,S.J.F., Greenblat,J., Konrat,R.
and Kay,L.E. (1997) Methods for measurement of intermolecular
NOEs by multinuclear NMR spectroscopy: application to a
bacteriophage   N-peptide/boxB RNA complex. J. Am. Chem.
Soc., 119, 6711–6721.
28. Gu ¨ ntert,P., Mumenthaler,C. and Wu ¨ thrich,K. (1997) Torsion
angle dynamics for NMR structure calculation with the new
program DYANA. J. Mol. Biol., 273, 283–298.
29. Brunger,A.T., Adams,P.D., Clore,G.M., Delano,W.L., Gros,P.,
Grosse-Kunstleve,R.W., Jiang,J.-S., Kuszewski,J., Nilges,M.,
Pannu,N.S. et al. (2001) Crystallography and NMR System
(CNS), 1.1 edn. Yale University, New Haven, CT.
30. Dominguez,C., Boelens,R. and Bonvin,A.M. (2003) HADDOCK:
a protein–protein docking approach based on biochemical or
biophysical information. J. Am. Chem. Soc., 125, 1731–1737.
31. Laskowski,R.A., Rullmannn,J.A., MacArthur,M.W., Kaptein,R.
and Thornton,J.M. (1996) AQUA and PROCHECK-NMR:
programs for checking the quality of protein structures solved by
NMR. J. Biomol. NMR., 8, 477–486.
32. Labib,K., Kearsey,S.E. and Difﬂey,J.F. (2001) MCM2-7 proteins
are essential components of prereplicative complexes that
accumulate cooperatively in the nucleus during G1-phase and are
required to establish, but not maintain, the S-phase checkpoint.
Mol. Biol. Cell., 12, 3658–3667.
33. Zhang,J., Yu,L., Wu,X., Zou,L., Sou,K.K., Wei,Z., Cheng,X.,
Zhu,G. and Liang,C. (2010) The interacting domains of hCdt1
and hMCM6 involved in the chromatin loading of the MCM
complex in human cells. Cell Cycle, 9, 4848–4857.
34. Thompson,J.D., Gibson,T.J., Plewniak,F., Jeanmougin,F. and
Higgins,D.G. (1997) The CLUSTAL_X windows interface: ﬂexible
3216 Nucleic Acids Research, 2012,Vol.40, No. 7strategies for multiple sequence alignment aided by quality
analysis tools. Nucleic Acids Res., 25, 4876–4882.
35. Chen,S., de Vries,M.A. and Bell,S.P. (2007) Orc6 is required for
dynamic recruitment of Cdt1 during repeated MCM2-7 loading.
Genes. Dev., 21, 2897–2907.
36. Chen,S. and Bell,S.P. (2011) CDK prevents MCM2-7 helicase
loading by inhibiting Cdt1 interaction with Orc6. Genes. Dev., 25,
363–372.
37. Liu,W., Pucci,B., Rossi,M., Pisani,F. and Ladenstein,R. (2008)
Structural analysis of the Sulfolobus solfataricus MCM protein
N-terminal domain. Nucleic Acids Res., 36, 3235–3243.
38. Pape,T., Meka,H., Chen,S., Vicentini,G., van Heel,M. and
Onesti,S. (2003) Hexameric ring structure of the full-length
archaeal MCM protein complex. EMBO Rep., 4, 1079–1083.
39. Gomez-Llorente,Y., Fletcher,R.J., Chen,X.S., Carazo,J.M. and
San Martin,C. (2005) Polymorphism and double hexamer
structure in the archaeal minichromosome maintenance (MCM)
helicase from Methanobacterium thermoautotrophicum. J. Biol.
Chem., 280, 40909–40915.
40. Costa,A., van Duinen,G., Medagli,B., Chong,J., Sakakibara,N.,
Kelman,Z., Nair,S.K., Patwardhan,A. and Onesti,S. (2008)
Cryo-electron microscopyreveals a novel DNA-binding site on the
MCM helicase. EMBO J., 27, 2250–2258.
41. Brewster,A.S., Wang,G., Yu,X., Greenleaf,W.B., Carazo,J.M.,
Tjajadia,M., Klein,M.G. and Chen,X.S. (2008) Crystal structure
of a near-full-length archaeal MCM: functional insights for an
AAA+ hexameric helicase. Proc. Natl Acad. Sci., 105,
20191–20196.
42. Khayrutdinov,B.I., Bae,W.J., Yun,Y.M., Lee,J.H., Tsuyama,T.,
Kim,J.J., Hwang,E., Ryu,K.S., Cheong,H.K., Cheong,C. et al.
(2009) Structure of the Cdt1 C-terminal domain: conservation of
the winged helix fold in replication licensing factors. Protein Sci.,
18, 2252–2264.
43. Jee,J., Mizuno,T., Kamada,K., Tochio,H., Chiba,Y., Yanagi,K.,
Yasuda,G., Hiroaki,H., Hanaoka,F. and Shirakawa,M. (2010)
Structure and mutagenesis studies of the C-terminal region of
licensing factor Cdt1 enable the identiﬁcation of key residues for
binding to replicative helicase MCM proteins. J. Biol. Chem., 285,
15931–15940.
44. Tjandra,N. and Bax,A. (1997) Direct measurement of distances
and angles in biomolecules by NMR in dilute liquid crystalline
medium of outstanding interest. Science, 278, 1111–1114.
Nucleic Acids Research,2012, Vol.40, No. 7 3217